Turnstone Biologics Corp. Net Income
Turnstone Biologics Corp. reported Net Income of -$5.49 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2025-08-08
- Turnstone Biologics Corp. net income (loss) attributable to parent for the quarter ending 2025-06-30 was -$5.49M.
- Turnstone Biologics Corp. net income (loss) attributable to parent for the quarter ending 2025-03-31 was -$11.81M.
- Turnstone Biologics Corp. net income (loss) attributable to parent for the quarter ending 2024-12-31 was -$12.87M.
- Turnstone Biologics Corp. net income (loss) attributable to parent for the quarter ending 2024-09-30 was -$17.03M.
- Turnstone Biologics Corp. net income (loss) attributable to parent for fiscal 2024 was -$70.84M.
- Turnstone Biologics Corp. net income (loss) attributable to parent for fiscal 2023 was -$55.20M.
- Turnstone Biologics Corp. net income (loss) attributable to parent for fiscal 2022 was -$30.83M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$5.49M 10-Q · filed 2025-08-08 | -$17.30M 10-Q · filed 2025-08-08 | -$30.17M derived: sum of 3 quarters · filed 2025-08-08 | -$47.20M derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | -$11.81M 10-Q · filed 2025-08-08 | -$24.68M derived: sum of 2 quarters · filed 2025-08-08 | -$41.71M derived: sum of 3 quarters · filed 2025-08-08 | -$63.01M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | -$12.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$29.90M derived: sum of 2 quarters · filed 2025-03-31 | -$51.21M derived: sum of 3 quarters · filed 2025-08-08 | -$70.84M 10-K · filed 2025-03-31 |
| 2024-09-30 | -$17.03M 10-Q · filed 2024-11-12 | -$38.34M derived: sum of 2 quarters · filed 2025-08-08 | -$57.97M 10-Q · filed 2024-11-12 | -$74.42M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | -$21.30M 10-Q · filed 2025-08-08 | -$40.93M 10-Q · filed 2025-08-08 | -$57.38M derived: sum of 3 quarters · filed 2025-08-08 | -$74.70M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$19.63M 10-Q · filed 2025-08-08 | -$36.08M derived: sum of 2 quarters · filed 2025-08-08 | -$53.40M derived: sum of 3 quarters · filed 2025-08-08 | -$74.90M derived: sum of 4 quarters · filed 2025-08-08 |
| 2023-12-31 | -$16.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$33.77M derived: sum of 2 quarters · filed 2025-03-31 | -$55.27M derived: sum of 3 quarters · filed 2025-03-31 | -$55.20M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$17.32M 10-Q · filed 2024-11-12 | -$38.82M derived: sum of 2 quarters · filed 2024-11-12 | -$38.75M 10-Q · filed 2024-11-12 | -$52.42M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$21.50M 10-Q · filed 2024-11-12 | -$21.43M 10-Q · filed 2024-08-14 | -$35.10M derived: sum of 3 quarters · filed 2024-11-12 | -$51.25M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-03-31 | $68.00K 10-Q · filed 2024-11-12 | -$13.60M derived: sum of 2 quarters · filed 2024-11-12 | -$29.75M derived: sum of 3 quarters · filed 2024-11-12 | -$18.15M derived: sum of 4 quarters · filed 2024-11-12 |
| 2022-12-31 | -$13.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$29.82M derived: sum of 2 quarters · filed 2024-03-22 | -$18.22M derived: sum of 3 quarters · filed 2024-03-22 | -$30.83M 10-K · filed 2024-03-22 |
| 2022-09-30 | -$16.15M 10-Q · filed 2023-11-13 | -$4.55M derived: sum of 2 quarters · filed 2023-11-13 | -$17.17M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $11.60M 10-Q · filed 2023-11-13 | -$1.02M 10-Q · filed 2023-09-01 | ||
| 2022-03-31 | -$12.62M 10-Q · filed 2023-11-13 |